GSK : UBS sticks Neutral
Published on 01/16/2026 at 05:51 am EST
MarketScreener with dpa-AFX Analyser
Share
In his latest research note, analyst Matthew Weston confirms his recommendation. The broker UBS is keeping its Neutral rating. No major update to the target price set at GBX 1900 compared to GBX 1940.
© MarketScreener with dpa-AFX Analyser -
2026
Share



















